Comparative effectiveness of JAK inhibitors and biologic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis.
The Korean journal of internal medicine（2023）
摘要
Our interim findings reveal JAKi have comparable effectiveness and safety to bDMARDs at 24 weeks after treatment initiation.
更多查看译文
关键词
Janus kinase inhibitor, Tumor necrosis factor inhibitors, Comparative effectiveness research, Safety, Rheumatoid arthritis
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要